These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 15189916)
1. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Wongsurakiat P; Maranetra KN; Wasi C; Kositanont U; Dejsomritrutai W; Charoenratanakul S Chest; 2004 Jun; 125(6):2011-20. PubMed ID: 15189916 [TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797 [TBL] [Abstract][Full Text] [Related]
3. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination. Menon B; Gurnani M; Aggarwal B Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444 [TBL] [Abstract][Full Text] [Related]
4. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study. Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD. Mulpuru S; Li L; Ye L; Hatchette T; Andrew MK; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA; Chest; 2019 Jan; 155(1):69-78. PubMed ID: 30616737 [TBL] [Abstract][Full Text] [Related]
6. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Gorse GJ; O'connor TZ; Young SL; Habib MP; Wittes J; Neuzil KM; Nichol KL Chest; 2006 Oct; 130(4):1109-16. PubMed ID: 17035445 [TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study. Regan AK; Klerk Nd; Moore HC; Omer SB; Shellam G; Effler PV Vaccine; 2016 Jul; 34(32):3649-56. PubMed ID: 27216758 [TBL] [Abstract][Full Text] [Related]
9. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial]. Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of an influenza vaccine in a working population in Colombia]. Mesa Duque SS; Pérez Moreno A; Hurtado G; Arbeláez Montoya MP Rev Panam Salud Publica; 2001 Oct; 10(4):232-9. PubMed ID: 11715169 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination. Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Gravenstein S; Davidson HE; Taljaard M; Ogarek J; Gozalo P; Han L; Mor V Lancet Respir Med; 2017 Sep; 5(9):738-746. PubMed ID: 28736045 [TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness. Sanei F; Wilkinson T Ther Adv Respir Dis; 2016 Aug; 10(4):349-67. PubMed ID: 27193567 [TBL] [Abstract][Full Text] [Related]
16. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons. De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165 [TBL] [Abstract][Full Text] [Related]
17. Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):32-5. PubMed ID: 23325354 [TBL] [Abstract][Full Text] [Related]
18. Seasonal influenza vaccination in patients with COPD: a systematic literature review. Bekkat-Berkani R; Wilkinson T; Buchy P; Dos Santos G; Stefanidis D; Devaster JM; Meyer N BMC Pulm Med; 2017 May; 17(1):79. PubMed ID: 28468650 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795 [TBL] [Abstract][Full Text] [Related]
20. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]